RealReview

 Conclusion / Investment Strategy The company is in the highly competitive field having fragmented (big and small) players. Based on super earnings of FY21, the issue is at a P/E of 35+ and is fully priced. Being IPO under Rs. 250 cr. it will list in T2T with lower circuit limits and this may restrict speculative moves. Hence cash surplus/risk seekers may consider investing in this a “high risk - low return issue. ABOUT COMPANY: Exxaro Tiles Ltd. (ETL) is engaged in the manufacturing and marketing of vitrified tiles used for flooring solutions. Having started its operation in the manufacturing of frits, over the years it diversified and expanded to its current status. It manufactures broadly two products i.e. double charge vitrified tiles and glazed vitrified tiles. Its product basket has 1000+ designs and it is sold under its own brand "Exxaro". As of the date of filing its RHP, it had 2000+ registered dealers across 24 states/union territories with PAN India presence. It is...

Some of these companies have announced their subscription date and size of IPO. Some haven't as the company updates, you will get the information.  

 IPO is looking good Some positive of companies are The company is among top 5 players in domestic pharmaceutical formulation contract development and manufacturing organization(CDMO). The projected growth of CDMO is 14% from Fy 20 to Fy25 as per CRISIL.com Earning and profits are positive in the last three financials Debt to Equity ratio is 0.157 which is not bad. No listed peers in NSE/BSE. Cash flow from operation is positive in last three financials though net cash flow in FY21 is negative but enjoys positive net cash flow in FY20 & FY19 Keep one thing in mind that see how many times it is subscribed if subscription is in good numbers you may go for it, it may or may not give listing gains. Company can do good in upcoming years. This is just my view I am not a sebi registered agent.  Comment below if you have any questions or suggestions...